Mesial temporal lobe epilepsy (MTLE) is a focal epileptic disorder that is frequently associated with hippocampal sclerosis. This study investigated whether blocking angiogenesis prevents the development of seizures and hippocampal atrophy in the pilocarpine rat model of MTLE. To block angiogenesis, a subset of animals were given sunitinib orally. Continuous video recordings were performed to identify seizures. Brains were then extracted and sectioned, and hippocampal surfaces and angiogenesis were assessed. After a latent period of 6.6 ± 2.6 days, the sham-treated pilocarpine rats presented convulsive seizures, while the pilocarpine rats treated with sunitinib did not develop seizures. Sham-treated pilocarpine rats but not sunitinib-treated pilocarpine rats had significantly smaller hippocampi. Endothelial cell counts in sham-treated pilocarpine rats were significantly greater than in controls and sunitinibtreated pilocarpine rats. Blocking angiogenesis immediately following the initial insult in this animal model prevented thus angiogenesis and hippocampal atrophy and averted the development of clinical seizures.
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Introduction
Epilepsy is one of the most common neurological disorders affecting up to 1% of the population worldwide (Moshé et al., 2015) . It is estimated that approximately 50 per 100,000 children develop epilepsy each year (Neubauer et al., 2008) . The symptomatic epilepsies represent a significant proportion of epileptic disorders and often develop as a consequence of an initial brain insult such as infection, febrile seizures, vascular accidents, or head trauma (Engel, 1996; Gloor, 1997; French et al., 1993; Salanova et al., 1994) . The current pharmacological treatment of epilepsy is based on symptomatic management with anticonvulsant drugs that are ineffective in preventing the complex process of tissue Abbreviations: CA3, cornu ammonis 3; DAPI, 4,6-diamidino-2-phenylindole; DG, dentate gyrus; MTLE, mesial temporal lobe epilepsy; SE, status epilepticus; VEGF, vascular endothelial growth factor; VEGFR, vascular endothelial growth factor receptor.
* remodeling known as epileptogenesis that follows the initial brain injury and finally leads to chronic epilepsy (Pitkanen and Sutula, 2002; Sutula, 2003) . Dissecting the molecular and network mechanisms underlying epileptogenesis may guide the development of disease modifying agents and prevent this chronic condition that is often associated with significant morbidities.
Mesial temporal lobe epilepsy (MTLE) is a significant cause of childhood epilepsy. Among childhood epilepsy, MTLE is the most common symptomatic focal epileptic disorder with onset in late childhood to mid-adolescence. Up to 30% of children are medically intractable, often requiring surgical interventions (Engel, 1996; Wiebe et al., 2011) . In MTLE, where seizures originate from within the hippocampus and para-hippocampal structures such as the entorhinal cortex, and/or the temporal neocortex, there is an associated characteristic pattern of brain damage known as Ammon's horn sclerosis or mesial temporal sclerosis (Engel, 1996; Gloor, 1997; Wiebe et al., 2011) .
Similar behavioral, electroencephalographic and histopathological findings can be reproduced in laboratory animals. Pharmacologically-induced status epilepticus (SE) with convulsant agents, such as pilocarpine, damages the brain and leads 1-4 weeks later to a chronic condition of recurrent limbic seizures that are poorly controlled by antiepileptic drugs (Chakir et al., 2006; Curia et al., 2008; Löscher and Köhling, 2010) and to hippocampal atrophy
